Ikena and Inmagene have selected…
Ikena and Inmagene have selected Kristin Yarema, Ph.D., to lead [...]
Eli Lilly is walking through the…
Eli Lilly is walking through the Gate, inking a deal [...]
Australian life sciences venture…
Australian life sciences venture capital firm Brandon Capital has closed [...]
Novartis is serving up $60 million…
Novartis is serving up $60 million to partner with Matchpoint [...]
After ditching a plan to split…
After ditching a plan to split into two distinct companies, [...]
In a rare rebuke, FDA refuses to fully review Aeglea’s rare disease drug application
In a rare rebuke, FDA refuses to fully review Aeglea’s [...]
UPDATE: Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks. Why not just buy it?
UPDATE: Bristol Myers triples-down on Immatics, bringing deal to $4.2B [...]
Centessa dumps top program after evidence of tolerability issues stunt market potential
Centessa dumps top program after evidence of tolerability issues stunt [...]
Oncology biotech Atreca pulled into industry’s layoff whirlpool, cuts 25% of staff
Oncology biotech Atreca pulled into industry’s layoff whirlpool, cuts 25% [...]
Enochian CEO, facing short-seller attack, tries to distance biotech from co-founder arrested in murder-for-hire-plot
Enochian CEO, facing short-seller attack, tries to distance biotech from [...]